Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cibus (CBUS) Short-term Investments (2016 - 2022)

Historic Short-term Investments for Cibus (CBUS) over the last 7 years, with Q4 2022 value amounting to $99000.0.

  • Cibus' Short-term Investments fell 8016.03% to $99000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $99000.0, marking a year-over-year decrease of 8016.03%. This contributed to the annual value of $99000.0 for FY2022, which is 8016.03% down from last year.
  • According to the latest figures from Q4 2022, Cibus' Short-term Investments is $99000.0, which was down 8016.03% from $174000.0 recorded in Q3 2022.
  • Cibus' 5-year Short-term Investments high stood at $38.6 million for Q1 2020, and its period low was $9000.0 during Q2 2018.
  • Its 5-year average for Short-term Investments is $5.7 million, with a median of $393000.0 in 2021.
  • Its Short-term Investments has fluctuated over the past 5 years, first skyrocketed by 1260000.0% in 2018, then plummeted by 9868.75% in 2021.
  • Over the past 5 years, Cibus' Short-term Investments (Quarter) stood at $381000.0 in 2018, then changed by 0.0% to $381000.0 in 2019, then soared by 2970.34% to $11.7 million in 2020, then crashed by 95.73% to $499000.0 in 2021, then tumbled by 80.16% to $99000.0 in 2022.
  • Its Short-term Investments stands at $99000.0 for Q4 2022, versus $174000.0 for Q3 2022 and $545000.0 for Q2 2022.